Publication: Erratum to: An optimised age-based dosing regimen for single low-dose primaquine for blocking malaria transmission in Cambodia [BMC Medicine, 14, (2016) (171)], 10.1186/s12916-016-0701-8
Issued Date
2016-12-20
Resource Type
ISSN
17417015
Other identifier(s)
2-s2.0-85006757133
Rights
Mahidol University
Rights Holder(s)
SCOPUS
Bibliographic Citation
BMC Medicine. Vol.14, No.1 (2016)
Suggested Citation
Rithea Leang, Naw Htee Khu, Mavuto Mukaka, Mark Debackere, Rupam Tripura, Soy Ty Kheang, Say Chy, Neeraj Kak, Philippe Buchy, Arnaud Tarantola, Didier Menard, Arantxa Roca-Felterer, Rick M. Fairhurst, Sim Kheng, Sinoun Muth, Song Ngak, Arjen M. Dondorp, Nicholas J. White, Walter Robert John Taylor Erratum to: An optimised age-based dosing regimen for single low-dose primaquine for blocking malaria transmission in Cambodia [BMC Medicine, 14, (2016) (171)], 10.1186/s12916-016-0701-8. BMC Medicine. Vol.14, No.1 (2016). doi:10.1186/s12916-016-0765-5 Retrieved from: https://repository.li.mahidol.ac.th/handle/20.500.14594/40936
Research Projects
Organizational Units
Authors
Journal Issue
Thesis
Title
Erratum to: An optimised age-based dosing regimen for single low-dose primaquine for blocking malaria transmission in Cambodia [BMC Medicine, 14, (2016) (171)], 10.1186/s12916-016-0701-8
Other Contributor(s)
National Center for Parasitology
Mahidol University
Nuffield Department of Clinical Medicine
MSF Belgium Cambodia Malaria Program
University Research Co., LLC
University Research Co., LLC
Institut Pasteur du Cambodge
Malaria Consortium
National Institute of Allergy and Infectious Diseases
FHI 360 Cambodia Office
Hôpitaux universitaires de Genève
Mahidol University
Nuffield Department of Clinical Medicine
MSF Belgium Cambodia Malaria Program
University Research Co., LLC
University Research Co., LLC
Institut Pasteur du Cambodge
Malaria Consortium
National Institute of Allergy and Infectious Diseases
FHI 360 Cambodia Office
Hôpitaux universitaires de Genève
Abstract
© 2016 The Author(s). After publication of the original article [1], it came to the authors' attention that there was an error in the PQ pharmacokinetics sub-section of the Background section. The following sentence is affected: "There is no PK interaction between PQ and either artesunate-pyronaridine [76] or mefloquine [69, 77]; no PK interaction data exist for PQ and artemetherlumefantrine (AL)." This sentence should have read as follows: "AS pyronaridine increased PQ exposure by 15% without affecting significantly cPQ exposure [76]. There is no PK interaction between PQ and mefloquine [69, 77]; no PK interaction data exist for PQ and artemetherlumefantrine (AL).".